ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001419351

Mamoura Diversified Global Holding PJSC

CIK 0001419351 Name as filed on the most recent filing

Filed as Mamoura Diversified Global Holding PJSC (20)· Mubadala Development Co PJSC (1)

31 transaction lines · from 21 filings · filed 2017-03-06 to 2025-09-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

1 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-07-29 MidCap Apollo Institutional Private Lending
NONE 		P, Open-market purchase 773,328 acquired 24.16 18,683,604.48 Form 4, filing 0000950170-25-101063
2024-06-14 MidCap Apollo Institutional Private Lending
NONE 		P, Open-market purchase 1,667,108 acquired 25.95 43,261,452.60 Form 4, filing 0000950170-25-114223
2023-03-02 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 66,822 acquired 7.82 522,354.26 Form 4, filing 0001839882-23-005947
2023-03-01 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 48,867 acquired 7.94 388,082.17 Form 4, filing 0001387131-23-002722
2023-02-28 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 815 acquired 7.97 6,495.55 Form 4, filing 0001387131-23-002678
2023-02-27 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 52,500 acquired 7.69 403,725.00 Form 4, filing 0001387131-23-002560
2023-02-24 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 109,118 acquired 7.64 833,552.40 Form 4, filing 0001839882-23-004972
2023-02-23 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 51,864 acquired 7.79 403,792.36 Form 4, filing 0001387131-23-002375
2023-02-22 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 50,941 acquired 7.83 399,015.76 Form 4, filing 0001387131-23-002324
2023-02-21 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 94,418 acquired 7.74 731,125.78 Form 4, filing 0001387131-23-002285
2023-02-17 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 63,382 acquired 7.71 488,985.79 Form 4, filing 0001387131-23-002254
2023-02-16 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 42,682 acquired 7.90 337,042.68 Form 4, filing 0001387131-23-002226
2023-02-14 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 6,300 acquired 7.95 50,059.80 Form 4, filing 0001839882-23-003873
2023-02-13 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 32,474 acquired 7.97 258,837.26 Form 4, filing 0001839882-23-003743
2023-02-10 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 11,000 acquired 7.98 87,807.50 Form 4, filing 0001387131-23-001898
2023-02-01 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 600 acquired 7.97 4,782.00 Form 4, filing 0001839882-23-002830
2023-01-26 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 7,886 acquired 7.99 63,005.99 Form 4, filing 0001387131-23-000851
2023-01-25 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 24,526 acquired 7.88 193,267.33 Form 4, filing 0001839882-23-001552
2023-01-10 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 69,518 acquired 7.72 536,845.80 Form 4, filing 0001387131-23-000335
2023-01-09 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 76,046 acquired 7.64 580,839.35 Form 4, filing 0001387131-23-000335
2023-01-06 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 68,953 acquired 7.41 510,610.76 Form 4, filing 0001387131-23-000335
2023-01-05 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 80,035 acquired 7.38 590,554.25 Form 4, filing 0001387131-23-000335
2023-01-04 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 91,892 acquired 7.80 716,877.06 Form 4, filing 0001387131-23-000335
2023-01-03 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 141,646 acquired 7.50 1,063,010.74 Form 4, filing 0001387131-23-000335
2022-12-30 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 99,754 acquired 7.55 753,621.52 Form 4, filing 0001387131-23-000335
2022-12-29 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 84,622 acquired 7.71 652,774.11 Form 4, filing 0001387131-23-000335
2022-12-28 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 71,299 acquired 7.18 511,898.30 Form 4, filing 0001387131-23-000335
2022-12-27 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 145,652 acquired 7.24 1,054,403.96 Form 4, filing 0001387131-23-000335
2022-12-23 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 100,378 acquired 7.52 754,420.97 Form 4, filing 0001387131-23-000335
2021-04-16 Recursion Pharmaceuticals, Inc.
RXRX 		P, Open-market purchase 2,777,777 acquired 18.00 49,999,986.00 Form 4, filing 0001387131-21-004685
2017-03-03 Advanced Micro Devices Inc
AMD 		S, Open-market sale 45,000,000 disposed 13.63 613,350,000.00 Form 4, filing 0000947871-17-000192

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mamoura Diversified Global Holding PJSC, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001419351

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.